Cargando…
Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
This study attempted to assess the incidence and outcome of anthracycline cardiotoxicity and the role of dexrazoxane as a cardioprotectant in childhood solid tumors. The dexrazoxane group included 47 patients and the control group of historical cohort included 42. Dexrazoxane was given in the 10:1 r...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Medical Sciences
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923785/ https://www.ncbi.nlm.nih.gov/pubmed/20808678 http://dx.doi.org/10.3346/jkms.2010.25.9.1336 |